Keyphrases
Acute Kidney Injury
40%
Arrhythmia
54%
Arrhythmic Storm
36%
Atrial Fibrillation
55%
Atrial Fibrillation Ablation
42%
Automatic Detection
40%
Biosensing Technology
40%
Brugada Syndrome
42%
Cardiac Arrest
33%
Cardiac Chambers
40%
Cardiac Gating
48%
CD4 T Cells
40%
CD8+ T Cells
40%
Clinical Outcomes
32%
Clinical Presentation
60%
Computed Tomography Angiography
31%
Confidence Interval
54%
Congenital Long QT Syndrome
42%
Consecutive Patients
46%
Coronary Artery Disease
72%
Coupling Interval
30%
COVID-19
30%
Forced Diuresis
50%
Hazard Ratio
33%
Heart Rate
30%
Heart Rate Monitoring
40%
HIV Patients
40%
Long QT Syndrome
44%
Long QT Syndrome Type 3
60%
Percutaneous Coronary Intervention
44%
Photoplethysmography
40%
Polymorphic Ventricular Tachycardia
97%
Pulmonary Vein Isolation
42%
QT Interval
52%
QT Prolongation
58%
Quinidine
60%
Ranolazine
40%
Risk Stratification
51%
Sensing Receptors
40%
ST-elevation Myocardial Infarction (STEMI)
61%
Teenagers
40%
Torsades Des Pointes
62%
Transcatheter Aortic Valve Implantation
100%
Troponin
46%
Troponin Levels
45%
Ventricular Arrhythmia
31%
Ventricular Fibrillation
67%
Zinc
40%
Zinc Detection
40%
Zn2+
40%
Medicine and Dentistry
Acute Kidney Injury
23%
Aortic Stenosis
26%
Apoplexy
20%
Atrial Fibrillation
64%
Atrial Fibrillation Ablation
22%
Biological Marker
22%
Brugada Syndrome
40%
Cardiac Dysrhythmia
60%
Cardiovascular System
43%
Cohort Analysis
49%
Computed Tomography Angiography
34%
Coronary Artery Disease
45%
COVID-19
40%
Diabetes Mellitus
37%
Diuresis
40%
Drug-Eluting Stent
28%
Dyspnea
26%
Electrocardiogram
44%
Faintness
20%
Hazard Ratio
23%
Heart Arrest
45%
Heart Rhythm
24%
Human Tissue
20%
Implantable Automatic Defibrillator
40%
Infection
40%
Left Atrium
22%
Metabolic Syndrome
20%
Monomorphic Ventricular Tachycardia
24%
Palpitations
20%
Patient History of Coronary Artery Bypass Graft
20%
Percutaneous Aortic Valve Replacement
100%
Percutaneous Coronary Intervention
44%
Pericarditis
20%
Photoelectric Plethysmography
36%
Polymorphic Ventricular Tachycardia
45%
Prevalence
29%
Pulmonary Artery
20%
Pulmonary Vein Isolation
42%
QT Interval
25%
QT Prolongation
56%
QTc Interval
34%
Risk Stratification
24%
Sex Difference
20%
Sodium Channel Blocker
20%
ST Segment Elevation Myocardial Infarction
40%
T Wave
23%
Torsade Des Pointes
46%
Troponin
30%
Ventricular Fibrillation
44%
Ventricular Tachycardia
52%
